The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characteristics of early-onset versus average-onset gastroesophageal adenocarcinoma.
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; Elevar Therapeutics; Guardant Health; Taiho Oncology
Speakers' Bureau - AstraZeneca; Taiho Oncology
Research Funding - Taiho Pharmaceutical
 
Emily Teslow
Employment - Tempus AI
Stock and Other Ownership Interests - Tempus AI
Travel, Accommodations, Expenses - Tempus AI
 
Yingying Yu
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Binyam Yilma
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Stamatina Fragkogianni
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Melissa Stoppler
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Lilly (Inst)